Sotrovimab to prevent severe COVID-19 in high-risk patients infected with Omicron BA.2

Detalles Bibliográficos
Autores principales: Martin-Blondel, Guillaume, Marcelin, Anne-Genevieve, Soulié, Cathia, Kaisaridi, Sofia, Lusivika-Nzinga, Clovis, Dorival, Céline, Nailler, Laura, Boston, Anaïs, Melenotte, Cléa, Cabié, André, Choquet, Christophe, Coustillères, François, Martellosio, Jean-Philippe, Gaube, Géraldine, Trinh-Duc, Albert, Ronchetti, Anne-Marie, Pourcher, Valerie, Chauveau, Marie, Lacombe, Karine, Peiffer-Smadja, Nathan, Housset, Pierre, Perrot, Aurore, Pialoux, Gilles, Martin, Aurélie, Dubee, Vincent, Devaux, Mathilde, Frey, Jérôme, Cazanave, Charles, Liblau, Roland, Carrat, Fabrice, Yordanov, Youri
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The British Infection Association. Published by Elsevier Ltd. 2022
Materias:
Letter to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9254651/
https://www.ncbi.nlm.nih.gov/pubmed/35803386
http://dx.doi.org/10.1016/j.jinf.2022.06.033

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9254651/
https://www.ncbi.nlm.nih.gov/pubmed/35803386
http://dx.doi.org/10.1016/j.jinf.2022.06.033

Ejemplares similares